Duke Gets Go Ahead Funding To Roll Out Next-Generation Coronavirus Vaccine

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

https://corporate.dukehealth.org/news/duke-researchers-receive-grant-roll-out-next-generation-coronavirus-vaccine